Not Tagged
Not Tagged
['sclc', 'nsclc', 'pdl']
#asco22 dr. oladimeji akinboro from presents pooled analysis of 12 trials comparing pd(l)1 therapy +/- chemo for pdl1 high nsclc. large data set here and looking at os as a composite endpoint of safety/efficacy. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him